AstraZeneca's omega-3 treatment for high triglycerides wins FDA approval

05/12/2014 | PharmTech.com

AstraZeneca's omega-3 therapy for adults with severely high triglycerides of 500 mg/dL or greater has been approved by the U.S. Food and Drug Administration. Epanova is the first prescription medication approved by the FDA that contains omega-3 in free fatty acid form.

View Full Article in:

PharmTech.com

Published in Brief: